Literature DB >> 32690604

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.

Jens Rittscher1,2,3,4, Viktor H Koelzer5,6,7, Korsuk Sirinukunwattana8,2,3, Enric Domingo5, Susan D Richman9, Keara L Redmond10, Andrew Blake11, Clare Verrill3,12,13, Simon J Leedham14,15, Aikaterini Chatzipli16, Claire Hardy16, Celina M Whalley17, Chieh-Hsi Wu18, Andrew D Beggs19, Ultan McDermott16, Philip D Dunne20, Angela Meade21, Steven M Walker22, Graeme I Murray23, Leslie Samuel24, Matthew Seymour25, Ian Tomlinson17,26, Phil Quirke9, Timothy Maughan27.   

Abstract

OBJECTIVE: Complex phenotypes captured on histological slides represent the biological processes at play in individual cancers, but the link to underlying molecular classification has not been clarified or systematised. In colorectal cancer (CRC), histological grading is a poor predictor of disease progression, and consensus molecular subtypes (CMSs) cannot be distinguished without gene expression profiling. We hypothesise that image analysis is a cost-effective tool to associate complex features of tissue organisation with molecular and outcome data and to resolve unclassifiable or heterogeneous cases. In this study, we present an image-based approach to predict CRC CMS from standard H&E sections using deep learning.
DESIGN: Training and evaluation of a neural network were performed using a total of n=1206 tissue sections with comprehensive multi-omic data from three independent datasets (training on FOCUS trial, n=278 patients; test on rectal cancer biopsies, GRAMPIAN cohort, n=144 patients; and The Cancer Genome Atlas (TCGA), n=430 patients). Ground truth CMS calls were ascertained by matching random forest and single sample predictions from CMS classifier.
RESULTS: Image-based CMS (imCMS) accurately classified slides in unseen datasets from TCGA (n=431 slides, AUC)=0.84) and rectal cancer biopsies (n=265 slides, AUC=0.85). imCMS spatially resolved intratumoural heterogeneity and provided secondary calls correlating with bioinformatic prediction from molecular data. imCMS classified samples previously unclassifiable by RNA expression profiling, reproduced the expected correlations with genomic and epigenetic alterations and showed similar prognostic associations as transcriptomic CMS.
CONCLUSION: This study shows that a prediction of RNA expression classifiers can be made from H&E images, opening the door to simple, cheap and reliable biological stratification within routine workflows. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  colorectal pathology; computerised image analysis; molecular pathology

Mesh:

Substances:

Year:  2020        PMID: 32690604      PMCID: PMC7873419          DOI: 10.1136/gutjnl-2019-319866

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.

Authors:  Nan Song; Katherine L Pogue-Geile; Patrick G Gavin; Greg Yothers; S Rim Kim; Nicole L Johnson; Corey Lipchik; Carmen J Allegra; Nicholas J Petrelli; Michael J O'Connell; Norman Wolmark; Soonmyung Paik
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

2.  Artificial intelligence-the third revolution in pathology.

Authors:  Manuel Salto-Tellez; Perry Maxwell; Peter Hamilton
Journal:  Histopathology       Date:  2019-02       Impact factor: 5.087

Review 3.  Molecular pathology - the value of an integrative approach.

Authors:  Manuel Salto-Tellez; Jacqueline A James; Peter W Hamilton
Journal:  Mol Oncol       Date:  2014-08-12       Impact factor: 6.603

4.  Stromal contribution to the colorectal cancer transcriptome.

Authors:  Claudio Isella; Andrea Terrasi; Sara Erika Bellomo; Consalvo Petti; Giovanni Galatola; Andrea Muratore; Alfredo Mellano; Rebecca Senetta; Adele Cassenti; Cristina Sonetto; Giorgio Inghirami; Livio Trusolino; Zsolt Fekete; Mark De Ridder; Paola Cassoni; Guy Storme; Andrea Bertotti; Enzo Medico
Journal:  Nat Genet       Date:  2015-02-23       Impact factor: 38.330

5.  Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility.

Authors:  Susanna B Park; Cindy S Y Lin; Arun V Krishnan; David Goldstein; Michael L Friedlander; Matthew C Kiernan
Journal:  Oncologist       Date:  2011-04-08

Review 6.  Tumour heterogeneity and resistance to cancer therapies.

Authors:  Ibiayi Dagogo-Jack; Alice T Shaw
Journal:  Nat Rev Clin Oncol       Date:  2017-11-08       Impact factor: 66.675

Review 7.  Image analysis and machine learning in digital pathology: Challenges and opportunities.

Authors:  Anant Madabhushi; George Lee
Journal:  Med Image Anal       Date:  2016-07-04       Impact factor: 8.545

8.  Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.

Authors:  Nicolas Coudray; Paolo Santiago Ocampo; Theodore Sakellaropoulos; Navneet Narula; Matija Snuderl; David Fenyö; Andre L Moreira; Narges Razavian; Aristotelis Tsirigos
Journal:  Nat Med       Date:  2018-09-17       Impact factor: 53.440

9.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

10.  Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.

Authors:  Matthew Alderdice; Susan D Richman; Simon Gollins; James P Stewart; Chris Hurt; Richard Adams; Amy Mb McCorry; Aideen C Roddy; Dale Vimalachandran; Claudio Isella; Enzo Medico; Tim Maughan; Darragh G McArt; Mark Lawler; Philip D Dunne
Journal:  J Pathol       Date:  2018-03-25       Impact factor: 7.996

View more
  39 in total

Review 1.  Deep learning in histopathology: the path to the clinic.

Authors:  Jeroen van der Laak; Geert Litjens; Francesco Ciompi
Journal:  Nat Med       Date:  2021-05-14       Impact factor: 53.440

Review 2.  Artificial intelligence in histopathology: enhancing cancer research and clinical oncology.

Authors:  Artem Shmatko; Narmin Ghaffari Laleh; Moritz Gerstung; Jakob Nikolas Kather
Journal:  Nat Cancer       Date:  2022-09-22

3.  Swarm learning for decentralized artificial intelligence in cancer histopathology.

Authors:  Oliver Lester Saldanha; Philip Quirke; Nicholas P West; Jacqueline A James; Maurice B Loughrey; Heike I Grabsch; Manuel Salto-Tellez; Elizabeth Alwers; Didem Cifci; Narmin Ghaffari Laleh; Tobias Seibel; Richard Gray; Gordon G A Hutchins; Hermann Brenner; Marko van Treeck; Tanwei Yuan; Titus J Brinker; Jenny Chang-Claude; Firas Khader; Andreas Schuppert; Tom Luedde; Christian Trautwein; Hannah Sophie Muti; Sebastian Foersch; Michael Hoffmeister; Daniel Truhn; Jakob Nikolas Kather
Journal:  Nat Med       Date:  2022-04-25       Impact factor: 87.241

Review 4.  Deep Learning on Histopathological Images for Colorectal Cancer Diagnosis: A Systematic Review.

Authors:  Athena Davri; Effrosyni Birbas; Theofilos Kanavos; Georgios Ntritsos; Nikolaos Giannakeas; Alexandros T Tzallas; Anna Batistatou
Journal:  Diagnostics (Basel)       Date:  2022-03-29

5.  Improving feature extraction from histopathological images through a fine-tuning ImageNet model.

Authors:  Xingyu Li; Min Cen; Jinfeng Xu; Hong Zhang; Xu Steven Xu
Journal:  J Pathol Inform       Date:  2022-06-30

6.  Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging.

Authors:  Esther Strating; Emma Wassenaar; Mathijs Verhagen; Paulien Rauwerdink; Susanne van Schelven; Ignace de Hingh; Inne Borel Rinkes; Djamila Boerma; Arjen Witkamp; Miangela Lacle; Riccardo Fodde; Richard Volckmann; Jan Koster; Kris Stedingk; Frederik Giesel; Remmert de Roos; Alex Poot; Guus Bol; Marnix Lam; Sjoerd Elias; Onno Kranenburg
Journal:  Br J Cancer       Date:  2022-03-16       Impact factor: 9.075

7.  Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Authors:  Ronja S Adam; Dennis Poel; Leandro Ferreira Moreno; Joey M A Spronck; Tim R de Back; Arezo Torang; Patricia M Gomez Barila; Sanne Ten Hoorn; Florian Markowetz; Xin Wang; Henk M W Verheul; Tineke E Buffart; Louis Vermeulen
Journal:  Mol Oncol       Date:  2022-04-29       Impact factor: 7.449

Review 8.  State of machine and deep learning in histopathological applications in digestive diseases.

Authors:  Soma Kobayashi; Joel H Saltz; Vincent W Yang
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

9.  Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.

Authors:  Peter W Eide; Seyed H Moosavi; Ina A Eilertsen; Tuva H Brunsell; Jonas Langerud; Kaja C G Berg; Bård I Røsok; Bjørn A Bjørnbeth; Arild Nesbakken; Ragnhild A Lothe; Anita Sveen
Journal:  NPJ Genom Med       Date:  2021-07-14       Impact factor: 8.617

10.  Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Sanne Ten Hoorn; Tim R de Back; Dirkje W Sommeijer; Louis Vermeulen
Journal:  J Natl Cancer Inst       Date:  2022-04-11       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.